Literature DB >> 7540527

Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash.

M F McMullin1, M B Finch.   

Abstract

A patient with Felty's syndrome and rheumatoid arthritis was treated with recombinant granulocyte stimulating factor rhG-CSF (Neupogen) in view of severe neutropenia. He had a prompt rise in his neutrophil count and associated with this a severe flare of his arthritis and a skin rash. rhG-CSF was stopped, his neutrophil count fell rapidly and his symptoms resolved. rhG-CSF and the resulting rise in neutrophil count may be associated with flare of autoimmune disease in susceptible individuals.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7540527     DOI： 10.1007/bf02214945

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  19 in total

1.  GM-CSF versus G-CSF in the treatment of infectious complication in Felty's syndrome--a case report.

Authors:  U Kaiser; M Klausmann; G Richter; K H Pflüger
Journal:  Ann Hematol       Date:  1992-04       Impact factor: 3.673

2.  Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia.

Authors:  M A Wodzinski; K K Hampton; J T Reilly
Journal:  Br J Haematol       Date:  1991-02       Impact factor: 6.998

3.  Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.

Authors:  B P Hazenberg; M A Van Leeuwen; M H Van Rijswijk; A C Stern; E Vellenga
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

Review 4.  Neutrophil activation by recombinant cytokines.

Authors:  M J Steinbeck; J A Roth
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

5.  Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.

Authors:  R Repp; T Valerius; A Sendler; M Gramatzki; H Iro; J R Kalden; E Platzer
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

6.  Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment.

Authors:  H J Ross; L A Moy; R Kaplan; R A Figlin
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

7.  GM-CSF in the treatment of Felty syndrome.

Authors:  G Joseph; D H Neustadt; J Hamm; M Kellihan; T Hadley
Journal:  Am J Hematol       Date:  1991-05       Impact factor: 10.047

8.  Prospective evaluation of the chemiluminescence test for the detection of granulocyte antibodies: comparison with the granulocyte immunofluorescence test.

Authors:  G F Lucas
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

9.  Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  A S Lübbe; N Schwella; H Riess; D Huhn
Journal:  Blut       Date:  1990-12

10.  Felty's syndrome: favorable response to granulocyte-macrophage colony-stimulating factor in the acute phase.

Authors:  U Kaiser; M Klausmann; G Kolb; K H Pflüger; K Havemann
Journal:  Acta Haematol       Date:  1992       Impact factor: 2.195
View more
  5 in total

Review 1.  Cytokine-induced autoimmune disorders.

Authors:  P Miossec
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 2.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

3.  Felty's Syndrome, Insights and Updates.

Authors:  Mohammad Bagher Owlia; Kam Newman; Mojtaba Akhtari
Journal:  Open Rheumatol J       Date:  2014-12-31

4.  C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.

Authors:  Lars Hornum; Anker Jon Hansen; Ditte Tornehave; Marianne Scheel Fjording; Paula Colmenero; Inger Falbe Wätjen; Niels Henrik Søe Nielsen; Henning Bliddal; Else Marie Bartels
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

Review 5.  Porto-Sinusoidal Vascular Disease as the Cause of Portal Hypertension in Felty's Syndrome: A Case Report and Literature Review.

Authors:  Song Yang; Min Quan; Yue Li; Calvin Qian Pan; Huichun Xing
Journal:  Biomed Res Int       Date:  2020-07-01       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.